Skip to content
Screener

MapLight Therapeutics, Inc. MPLT Q3 2025 earnings

Reported December 4, 2025 · Before market open

EPS-$37.18Miss by $35.46
EPS estimate-$1.72

Next report

Dec 3, 2026 (in 2 months)
EPS estimate-$1.22

Financials

Q3 2025

Income statement

See full
Operating income-$31.5M-50.8%
Net income-$29.4M-54.7%
EPS (diluted)-$37.18-48.2%

Balance sheet

See full
Cash & equivalents$64.1M—
Total debt$6.0M—
Total equity-$274.2M-59.1%
Total assets$257.2M—

Versus estimates

Diluted EPS

Q2 2026-$1.32Beat by $0.03Q1 2026-$1.32Beat by $0.03Q4 2025-$1.34Miss by $0.38
Q3 2025-$37.18Miss by $35.46

FAQ

When did MapLight Therapeutics, Inc. report Q3 2025 earnings?
MapLight Therapeutics, Inc. (MPLT) reported Q3 2025 earnings on December 4, 2025 before market open.
What were MapLight Therapeutics, Inc.'s Q3 2025 revenue and EPS?
MapLight Therapeutics, Inc. reported eps of $-37.18 for Q3 2025.
Did MapLight Therapeutics, Inc. beat estimates in Q3 2025?
EPS missed the consensus estimate of $-1.72 by $35.46.
Where can I find MapLight Therapeutics, Inc.'s Q3 2025 SEC filings?
You can read the 8-K earnings release (0001193125-25-307450) and the 10-Q periodic report (0001193125-25-307453) directly on SEC EDGAR. The filing index links above go to sec.gov.